HALO: Halozyme Therapeutics, Inc. Stock

by  •  • Comments Off on HALO: Halozyme Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 6,902.84
Enterprise Value ($M) 8,233.96
Book Value ($M) 482.27
Book Value / Share 3.91
Price / Book 14.31
NCAV ($M) -452.23
NCAV / Share -3.67
Price / NCAV -15.26

Profitability (mra)
Return on Invested Capital (ROIC) 0.24
Return on Assets (ROA) 0.26
Return on Equity (ROE) 2.73

Liquidity (mrq)
Quick Ratio 7.30
Current Ratio 8.39

Balance Sheet (mrq) ($M)
Current Assets 1,262.03
Assets 2,196.53
Liabilities 1,714.26
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1,015.32
Operating Income 551.48
Net Income 444.09
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 479.06
Cash from Investing -262.72
Cash from Financing -218.86

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-13 13G State Street Corp 4.90 -8.78
04-28 13G/A BlackRock, Inc. 13.10 -13.34
11-12 13G/A Artisan Partners Limited Partnership 2.50 -53.16

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-02-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-10-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-30 296,683 1,472,072 20.15
2025-05-29 598,742 1,681,690 35.60
2025-05-28 520,458 1,561,118 33.34
2025-05-27 447,920 1,513,368 29.60

(click for more detail)

Similar Companies
GILD – Gilead Sciences, Inc. GLUE – Monte Rosa Therapeutics, Inc.
GOSS – Gossamer Bio, Inc. HLVX – HilleVax, Inc.
HOWL – Werewolf Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io